Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China · Delayed Price · Currency is CNY 18.35
-0.24 (-1.29%)
Nov 17, 2025, 2:14 PM CST
SHA:600161 Market Cap
SHA:600161 has a market cap or net worth of 36.76 billion as of November 14, 2025. Its market cap has decreased by -15.08% in one year.
Market Cap
36.76B
Enterprise Value
38.58B
Revenue
6.42B
Ranking
n/a
PE Ratio
28.18
Stock Price
18.35
Market Cap Chart
Since March 8, 2000, SHA:600161's market cap has increased from 3.95B to 36.76B, an increase of 831.20%. That is a compound annual growth rate of 9.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 36.76B | -9.32% |
| Dec 31, 2024 | 40.54B | -20.49% |
| Dec 29, 2023 | 50.98B | 30.38% |
| Dec 30, 2022 | 39.10B | -1.67% |
| Dec 31, 2021 | 39.77B | -23.98% |
| Dec 31, 2020 | 52.31B | 79.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 417.34B |
| WuXi AppTec | 282.16B |
| Shenzhen Mindray Bio-Medical Electronics | 251.19B |
| Sichuan Biokin Pharmaceutical | 153.43B |
| Aier Eye Hospital Group | 113.87B |
| Shanghai United Imaging Healthcare | 112.24B |
| Zhangzhou Pientzehuang Pharmaceutical., | 109.07B |
| Yunnan Baiyao Group Co.,Ltd | 101.10B |